Global Angina Pectoris Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Angina Pectoris Market was valued at $12.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.2% CAGR, to an estimated market size of $15.6 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global angina pectoris market comprises pharmaceutical treatments and therapeutic interventions designed to manage chest pain or discomfort resulting from myocardial ischemia. The scope includes medications for stable angina, unstable angina, and Prinzmetal angina, focusing on symptom relief and the prevention of cardiovascular events through vasodilators, beta-blockers, and novel metabolic modulators.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Angina Pectoris Market in the period 2025-30:
- The rising global prevalence of Cardiovascular Diseases (CVD) and sedentary lifestyles is the primary driver for market expansion.
- A rapidly expanding geriatric population is increasing the patient pool susceptible to coronary artery disease and chronic angina.
- There is a significant shift toward precision cardiology and personalized medicine based on specific genetic markers.
- The adoption of late sodium current inhibitors and metabolic modulators is transforming chronic management paradigms.
- Integration of digital health tools and wearable diagnostic devices is improving drug titration and patient adherence protocols.
- Emerging evidence of Long COVID complications is creating new demand for managing angina-like symptoms in post-viral patients.
- Market growth is partially restrained by the increasing availability of generic alternatives following major patent expirations.
- Strategic focus on combination therapies is becoming the standard for treating resistant or refractory angina cases.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Beta-blockers
- Nitrates
- Calcium Channel Blockers
- Novel Therapies & Others